news
FDA approves Tafinlar/Mekinist for BRAF V600-mutant melanoma
The FDA has approved Tafinlar in combination with Mekinist for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutation...
List view / Grid view
Formulation
webinar
ISO/IEC 17025:2017 – New definitions for specifications, decision rules & risk assessments for calibrations
30 April 2018 | By Vaisala
The 2017 revision to ISO/IEC 17025 includes better guidance on conformity and a new risk-based approach. In this webinar we discuss the revision in terms of temperature and humidity calibration in life science environments...
news
New uses for existing antiviral drugs
A test of 55 antiviral drugs that are known to be safe in humans found 7 compounds that show new effects against multiple viruses...
news
Imaging may allow safe tPA treatment of patients with unwitnessed strokes
The mismatch between two MRI methods could signify early stroke status, allowing the use of 'clot-busting' drug...
news
Anticholinergic medications linked to dementia
Long-term use of some anticholinergic medications are associated with an increased risk of dementia – according to a new study led by the University of East Anglia...
news
B&W Tek Announces QTRam for Content and Blend Uniformity Testing
B&W Tek is proud to announce the QTRam™ for nondestructive and real-time pharmaceutical content and blend uniformity measurement powered by the award-winning STRaman™ technology at CPhI North America on Tuesday, April 24, 2018...
news
FDA advances the development of innovative products for OUD
The FDA has announced its latest action to encourage and support the development of treatment options for people with opioid use disorder...
news
Anti-TNFα therapy may help reduce risk of developing Parkinson’s disease
Mount Sinai shows the potential link between Parkinson's disease and inflammatory bowel disease, suggests anti-TNFα therapy may reduce the risk of developing Parkinson's...
news
FDA approves first therapy for rare inherited form of rickets, x-linked hypophosphatemia
The FDA has approved Crysvita, the first drug approved to treat adults and children ages 1 year and older with x-linked hypophosphatemia, a rare, inherited form of rickets...
news
Diabetes drug may not reduce risk of death
One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings...
news
Iron supplements may influence the development of colon cancer
Two common iron compounds increase the formation of a known biomarker for cancer...
article
Formulation, Development & Delivery In-Depth Focus 2018
In this In-Depth Focus; early biotherapeutic lead optimisation for more efficient drug discovery and development, and turning promising compounds into drug candidates.
news
Vaccine suppresses peanut allergies in mice
Researchers aim to develop a new immunotherapy that could alter the immune reactions to food. The result: Extended relief from peanut allergies...
news
First-in-Human trial of cannabis-based therapy for Parkinson’s initiated
GB Sciences, Inc. is planning to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable First-In-Human data on its proprietary cannabis-based therapies...
article
Issue #2 2018 – Digital Version
In this issue; recent developments in turning promising compounds into drug candidates, reviewing the latest trends in pharmaceutical microbiology and their implications, and a roundtable debate featuring the views of five industry leaders.
